Anzen Industries Raises $2.2M to Revolutionize Chemical Manufacturing and Shift Operations to US
UK deeptech startup Anzen Industries secured $2.2 million in pre-seed funding, led by LocalGlobe and Creator Fund, to transform complex chemical manufacturing. The investment will fuel its biomanufacturing innovation and facilitate a strategic move of operations to the US, with a new facility in California. Anzen will produce high-value molecules for cosmetics, food, and critical minerals using proprietary enzyme reactor technology, advanced immobilisation, and AI, aiming for more agile, scalable, and cost-efficient production through cell-free systems.
Anzen Industries, a deeptech startup based in the UK, has successfully raised $2.2 million (£1.7 million) in a pre-seed funding round. The investment was led by LocalGlobe and Creator Fund, with additional participation from strategic angel investors across the UK, Europe, and the US. This capital infusion is earmarked to significantly advance the company's mission: transforming the production of complex chemical molecules and bolstering industrial supply chain resilience through its innovative biomanufacturing technology.A key strategic initiative supported by this funding is Anzen Industries' relocation of its primary operations to the United States, which is recognized as one of the world's largest chemical manufacturing markets. The company plans to establish its first biomanufacturing facility in California. Once operational, this plant will be dedicated to manufacturing high-value, critical molecules that serve as active ingredients in cosmetics, fragrances, and food products. Additionally, it will offer innovative solutions for critical minerals processing, expanding Anzen's industrial relevance.Co-founder and CEO Amy Locks noted that while Europe's scientific ecosystem was crucial for the company's early development, the US offers a more advanced industrial and innovation environment ideal for global scaling. Anzen Industries, co-founded by scientists Amy Locks and Pedro Lovatt Garcia, utilizes a unique combination of proprietary enzyme reactor technology, advanced immobilisation techniques, and AI-driven design to redefine molecular production. This first-principles approach, employing isolated and tunable enzymes in modular reactors, aims to make chemical manufacturing more efficient, cost-effective, and faster than traditional methods, ultimately accelerating time to market and enhancing supply chain sovereignty for critical chemicals.
